1. Possible teratogenic effects of supplementation

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Pentamidine administration may spring a leak

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. PUVA increases the risk of cancer

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. The elderly have a high risk of ADRs and drug interactions

   Newsletter Article 27 January 2013 Pages: 2 - 4

5. Accidental exposure to doxorubicin

   Newsletter Article 27 January 2013 Pages: 4 - 4

6. Alteplase/heparin

   Newsletter Article 27 January 2013 Pages: 4 - 4

7. Aminocaproic acid

   Newsletter Article 27 January 2013 Pages: 4 - 4

8. Amoxicillin

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Antineoplastics

   Newsletter Article 27 January 2013 Pages: 4 - 5

10. Antineoplastics + radiotherapy

    Newsletter Article 27 January 2013 Pages: 5 - 5

11. Atropine overdose

    Newsletter Article 27 January 2013 Pages: 5 - 5

12. Bleomycin see Cisplatin/etoposide/bleomycin

    Newsletter Article 27 January 2013 Pages: 5 - 5

13. Buserelin see Cyproterone/triptorelin/buserelin

    Newsletter Article 27 January 2013 Pages: 5 - 5

14. Captopril

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Carbamazepine see Fluoxetine interaction

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Cisplatin/etoposide/bleomycin

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Clonidine

    Newsletter Article 27 January 2013 Pages: 5 - 6

18. Clozapine

    Newsletter Article 27 January 2013 Pages: 6 - 6

19. Contraceptives

    Newsletter Article 27 January 2013 Pages: 6 - 6

20. Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 6 - 6

21. Cyproterone/triptorelin/buserelin

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Cytarabine

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Danazol

    Newsletter Article 27 January 2013 Pages: 6 - 7

24. Diltiazem

    Newsletter Article 27 January 2013 Pages: 7 - 7

25. Disulfiram

    Newsletter Article 27 January 2013 Pages: 7 - 7

26. Doxorubicin

    Newsletter Article 27 January 2013 Pages: 7 - 7

27. Etoposide see Cisplatin/etoposide/bleomycin

    Newsletter Article 27 January 2013 Pages: 7 - 7

28. Fenoterol

    Newsletter Article 27 January 2013 Pages: 7 - 7

29. Fluoxetine see Tricyclic antidepressants interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

30. Fluoxetine interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

31. Heparin see Alteplase/heparin

    Newsletter Article 27 January 2013 Pages: 8 - 8

32. Ketoconazole

    Newsletter Article 27 January 2013 Pages: 8 - 8

33. Lovastatin

    Newsletter Article 27 January 2013 Pages: 8 - 8

34. MAOIs

    Newsletter Article 27 January 2013 Pages: 8 - 8

35. Mefenamic acid

    Newsletter Article 27 January 2013 Pages: 8 - 8

36. Methotrexate see Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

37. Mitomycin

    Newsletter Article 27 January 2013 Pages: 8 - 9

38. Pentamidine

    Newsletter Article 27 January 2013 Pages: 9 - 9

39. Pertussis vaccine

    Newsletter Article 27 January 2013 Pages: 9 - 9

40. Pethidine

    Newsletter Article 27 January 2013 Pages: 9 - 9

41. Phenytoin

    Newsletter Article 27 January 2013 Pages: 9 - 9

42. Piperacillin interaction

    Newsletter Article 27 January 2013 Pages: 9 - 9

43. Piroxicam

    Newsletter Article 27 January 2013 Pages: 9 - 10

44. Procaine penicillin

    Newsletter Article 27 January 2013 Pages: 10 - 10

45. Propranolol withdrawal

    Newsletter Article 27 January 2013 Pages: 10 - 10

46. Psoralens + ultraviolet A light

    Newsletter Article 27 January 2013 Pages: 10 - 10

47. Retinol

    Newsletter Article 27 January 2013 Pages: 10 - 10

48. Tamoxifen

    Newsletter Article 27 January 2013 Pages: 10 - 10

49. Thrombolytics

    Newsletter Article 27 January 2013 Pages: 10 - 10

50. Tricyclic antidepressants interaction

    Newsletter Article 27 January 2013 Pages: 10 - 11